India Network Point-of-care Glucose Testing Market Size & Outlook
India network point-of-care glucose testing market, 2016-2028 (US$M)
Related Markets
India network point-of-care glucose testing market highlights
- The India network point-of-care glucose testing market generated a revenue of USD 50.9 million in 2021 and is expected to reach USD 71.6 million by 2028.
- The India market is expected to grow at a CAGR of 5% from 2022 to 2028.
- In terms of segment, accu-chek inform ii was the largest revenue generating types in 2021.
- StatStrip is the most lucrative types segment registering the fastest growth during the forecast period.
Network point-of-care glucose testing market data book summary
| Market revenue in 2021 | USD 50.9 million |
| Market revenue in 2028 | USD 71.6 million |
| Growth rate | 5% (CAGR from 2021 to 2028) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | StatStrip |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, India accounted for 4.1% of the global network point-of-care glucose testing market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, Japan network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2028.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 87.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 49.71% in 2021. Horizon Databook has segmented the India network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
Diabetes is one of the most common diseases in India, which necessitates keeping a proper track of diet as well as blood sugar levels in patients. Thus, glucometers have become vital in individualized management of diabetes.
As glucometers help avoid doctor visits and offer instant results, preference for glucometers in India has increased significantly. Presence of a large number of individuals suffering from diabetes in the country has propelled not only international manufacturers but also small-scale local companies to introduce potent POC glucose testing products in the Indian market.
Reasons to subscribe to India network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into India network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
India network point-of-care glucose testing market size, by types, 2016-2028 (US$M)
India Network Point-of-Care Glucose Testing Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
